SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-23-120787
Filing Date
2023-11-22
Accepted
2023-11-22 16:32:00
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-11-22

Document Format Files

Seq Description Document Type Size
1 ARS tm2329661d2_ars.pdf ARS 2529261
  Complete submission text file 0001104659-23-120787.txt   3485108
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38302 | Film No.: 231433938
SIC: 2834 Pharmaceutical Preparations